Lionel Carnot


Lionel Carnot is a Partner with Earlybird Venture Capital. He has served as a Director on the Board for iSTAR Medical since 2019.

Lionel contributes a wealth of know-how in the biotechnology, medtech, diagnostic, R&D tools and service fields. Prior to joining Earlybird, Lionel was a Managing Director with Bay City Capital, an associate with  The Pritzker Organization, and a principal at Oracle Partners, a healthcare hedge fund. He also held several positions in the industry, including Product Manager at Eli Lilly as well as several sales and marketing positions at Sanofi. Lionel was also a strategy and management consultant to the healthcare industry while at Booz Allen & Hamilton and Accenture Strategic Services. Lionel’s investment activities focus on medical-device companies, biotechnology, as well as diagnostic and specialty pharmaceuticals.

Lionel is a member of the Board of Directors of iQone Healthcare, Oculis SA, Priothera and iStar Medical. Previously he had board roles with Madrigal Pharmaceuticals (NASDAQ: MDGL), Reliant Pharmaceuticals, Merus N.V. (NASDAQ: MRUS), Pathway Diagnostics, BioSeek, Nexus Dx, and Nabsys.

Lionel holds an MBA with Distinction from INSEAD and an M.Sc. in Molecular Biology from the University of Geneva.

scroll to up
Sign up to receive company news alerts